Skip to content

Evaluation of the effectiveness of education with a mobile application on the prevention of atherosclerotic coronary artery diseases risk factors

Design, implementation, and evaluation of mobile application based on integrated behavior change model for primary prevention of atherosclerotic coronary artery disease risk factors.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200321046826N1
Enrollment
430
Registered
2021-11-05
Start date
2021-09-23
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerotic coronary artery disease. Atherosclerotic cardiovascular disease

Interventions

Intervention 1: Intervention group: The intervention includes three phases: pre-test, content education, and post-test. Pre-tests in both intervention and control groups are sent to their mobile phone

Sponsors

Primary Prevention of Cardiovascular Diseases Research Center, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Have two or more risk factors for coronary artery atherosclerosis include an unhealthy diet, physical inactivity, high blood pressure, high blood fats, high blood sugar, obesity, smoking. Obtain a risk score of 2.5-15% based on cardiovascular disease risk assessment. 75 - 18 years old Have a desire to participate in the study Have a smartphone or tablet Have the ability to work with mobile applications Intention to stay at the place of study for the next one year

Exclusion criteria

Exclusion criteria: History of cardiovascular diseases Physical disability Existence of other chronic diseases Mental Disease

Design outcomes

Primary

MeasureTime frame
Knowledge score about risk factors for coronary artery atherosclerotic disease. Timepoint: Before the intervention and six months after the intervention. Method of measurement: Researcher-made questionnaire on knowledge of risk factors for atherosclerotic coronary heart disease.;Risk perception score on risk factors for atherosclerotic coronary heart disease. Timepoint: Before the intervention and six months after the intervention. Method of measurement: Researcher-made risk perception questionnaire about risk factors for atherosclerotic coronary heart disease.;Attitude score on risk factors for atherosclerotic coronary artery disease. Timepoint: Before the intervention and six months after the intervention. Method of measurement: Researcher-made attitude questionnaire about risk factors for atherosclerotic coronary heart disease.;Perceived self-efficacy score on risk factors for atherosclerotic coronary heart disease. Timepoint: Before the intervention and six months after the intervention. Method of measurement: Researcher-made perceived self-efficacy questionnaire on risk factors for coronary atherosclerotic disease.;Perceived social support score on risk factors for coronary artery atherosclerotic disease. Timepoint: Before the intervention and six months after the intervention. Method of measurement: Researcher-made social support questionnaire on the risk factors for coronary atherosclerotic disease.;Score of preventive behavior on risk factors for atherosclerotic coronary artery disease. Timepoint: Before the intervention and six months after the intervention. Method of measurement: Researcher-made preventive behavior questionnaire on risk factors for atherosclerotic coronary heart disease.;Satisfaction with the use of mobile application. Timepoint: Six months after the intervention. Method of measurement: User Experience Questionnaire(UEQ) - Persian Version.

Secondary

MeasureTime frame
Blood pressure. Timepoint: Before the intervention and six months after the intervention. Method of measurement: Mercury sphygmomanometers.;Triglyceride. Timepoint: Before the intervention and six months after the intervention. Method of measurement: Spectrophotometry.;Low density lipoprotein (LDL). Timepoint: Before the intervention and six months after the intervention. Method of measurement: Spectrophotometry.;High Density Lipoprotein (HDL). Timepoint: Before the intervention and six months after the intervention. Method of measurement: Spectrophotometry.;Cholesterol. Timepoint: Before the intervention and six months after the intervention. Method of measurement: Spectrophotometry.;Fasting blood sugar. Timepoint: Before the intervention and six months after the intervention. Method of measurement: Spectrophotometry.;Body Mass Index (BMI). Timepoint: Before the intervention and six months after the intervention. Method of measurement: Calibrated weights, meters to measure height.;Weight. Timepoint: Before the intervention and six months after the intervention. Method of measurement: Digital scales.;Healthy eating habits. Timepoint: Before the intervention and six months after the intervention. Method of measurement: National Survey Questionnaire on non-communicable diseases risk factors-WHO STEPS Instrument.;Physical activity. Timepoint: Before the intervention and six months after the intervention. Method of measurement: International Physical Activity Questionnaire - Short Form (IPAQ).;Smoking. Timepoint: Before the intervention and six months after the intervention. Method of measurement: National Survey Questionnaire on non-communicable diseases risk factors-WHO STEPS Instrument.;Mental health. Timepoint: Before the intervention and six months after the intervention. Method of measurement: European Society of Cardiology (ESC) psychosocial screening instrument.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfsaneh Aein

Iran University of Medical Sciences

AFSANEH.AEIN@GMAIL.COM+2166947769

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026